Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →5
🟢 Low
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,580
Total Claims
$7.0M
Drug Cost
1,702
Beneficiaries
$4,092
Cost/Patient
Risk Score Breakdown 5/100
Score components are additive. Read full methodology
Peer Comparison vs. 2,486 Clinical Cardiac Electrophysiology providers
+194%
Cost per patient vs peers
$4,092 vs $1,390 avg
+121%
Brand preference vs peers
53.7% vs 24.3% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
Opioid Prescribing
0.1%
Opioid Rate
11
Opioid Claims
$43
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 5,683 claims · $6.8M
Generic: 4,897 claims · $174K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 2,071 | $2.5M |
| Rivaroxaban | 2,013 | $2.4M |
| Sacubitril/Valsartan | 693 | $874K |
| Dapagliflozin Propanediol | 381 | $439K |
| Dronedarone Hcl | 228 | $341K |
| Empagliflozin | 172 | $230K |
| Flecainide Acetate | 704 | $56K |
| Ranolazine | 69 | $15K |
| Carvedilol | 747 | $11K |
| Olmesartan Medoxomil | 165 | $9,941 |
| Amiodarone Hcl | 853 | $9,845 |
| Dabigatran Etexilate Mesylate | 19 | $6,913 |
| Rosuvastatin Calcium | 176 | $6,289 |
| Amlodipine Bes/Olmesartan Med | 70 | $6,270 |
| Digoxin | 186 | $5,748 |
Prescribing Profile
Patient Profile
78
Avg Age
46%
Female
2.27
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About